To evaluate the therapeutic effect of uPA inhibitor UK122 on DSS-induced colitis, we intraperitoneally administered 2 mg/kg or 4 mg/kg of UK122 or vehicle alone to C57BL/6 J mice treated with DSS from day 1 to 7 (Fig. 5A). The gene discussed is PLAU; the disease is colitis.